Open AccessCastleman disease of the pancreas mimicking pancreatic malignancy on 68Ga-DOTATATE and 18F-fluorodeoxyglucose positron emission tomography/computed tomography: A case report
Author(s) -
Sheng-Lu Liu,
Ming Luo,
Hao-Xian Gou,
Xiaoli Yang,
Kai He
Publication year - 2022
Publication title -
world journal of gastrointestinal surgery
Language(s) - English
Resource type - Journals
ISSN - 1948-9366
DOI - 10.4240/wjgs.v14.i5.514
Subject(s) - medicine , positron emission tomography , pancreas , malignancy , hypervascularity , radiology , pathology , fluorodeoxyglucose , neuroendocrine tumors , castleman disease , nuclear medicine , disease
Castleman disease is an uncommon nonclonal lymphoproliferative disorder, which frequently mimics both benign and malignant abnormalities in several regions. Depending on the number of lymph nodes or regions involved, Castleman disease (CD) varies in diagnosis, treatment and prognosis. It rarely occurs in the pancreas alone without any distinct clinical feature and tends to be confused with pancreatic paraganglioma (PGL), neuroendocrine tumors (NETs), and primary tumors, thus impeding proper diagnosis and treatment.